Latest

macular degeneration

Featured Neuroscience Visual Neuroscience

·May 23, 2025·4 min read

Eye Surgery Technique Could Restore Vision in Macular Degeneration

Scientists have developed a novel surgical method allowing two retinal tissue grafts to be implanted in a single eye, advancing treatment strategies for dry age-related macular degeneration (AMD). This new approach enables side-by-side testing of grafts—one with retinal pigment epithelial (RPE) cells and one without—within the same lesion, using a specially designed clamp to maintain eye pressure and reduce damage.

Featured Neuroscience Visual Neuroscience

·April 22, 2025·4 min read

Rewiring Retinal Messages to Slow Vision Loss in AMD

Age-related macular degeneration (AMD), the leading cause of adult blindness, affects nearly half of Oklahomans over age 80. New research is uncovering how retinal cells communicate using microRNA and extracellular vesicles (EVs), with the goal of slowing AMD progression.

Featured Neuroscience Visual Neuroscience

·April 17, 2025·6 min read

Gold Nanoparticles Restore Vision in Macular Degeneration

A new study shows that gold nanoparticles injected into the retina can restore vision in mice with retinal degeneration, offering a less invasive alternative to current retinal prostheses. When activated by patterned infrared light, these nanoparticles stimulate retinal cells, bypassing damaged photoreceptors.

Featured Neuroscience Visual Neuroscience

·December 4, 2024·4 min read

Sleep Apnea May Increase Risk of Wet Macular Degeneration

A new study has linked moderate-to-severe obstructive sleep apnea (OSA), characterized by low oxygen levels overnight, with an increased risk of developing wet age-related macular degeneration (AMD). The research suggests nocturnal hypoxia could affect the oxygen-sensitive retina, contributing to AMD progression.

Featured Genetics Neuroscience Visual Neuroscience

·October 2, 2024·4 min read

Targeting Protein Reduces Macular Degeneration Symptoms

New research identifies a protein, TIMP3, overproduced in age-related macular degeneration (AMD) that may drive the disease’s progression. By targeting the enzyme linked to inflammation and drusen formation, scientists reduced early signs of AMD in stem cell models, offering hope for new treatments.

Featured Neuroscience Visual Neuroscience

·July 10, 2024·4 min read

Detecting Early Vision Loss in Macular Degeneration

A new study reveals that early changes in age-related macular degeneration (AMD) can lead to measurable local vision loss. Researchers used advanced imaging to find that iRORA lesions, early signs of retinal damage, significantly reduce visual acuity. This discovery could enhance monitoring and treatment of AMD, potentially preventing severe vision loss. The findings offer hope for earlier intervention in this progressive eye disease.

This shows an older man undergoing an eye exam.

Featured Neuroscience Visual Neuroscience

·June 5, 2024·3 min read

New Breakthrough Treatment for Age-Related Macular Degeneration

Researchers discovered that boosting the protein IRAK-M in retinal cells can effectively treat age-related macular degeneration (AMD). This revolutionary therapy offers a comprehensive approach to AMD, a leading cause of vision loss affecting 200 million people worldwide.

Featured Neuroscience Visual Neuroscience

·January 9, 2023·5 min read

Two Separate Eye Diseases May Contribute to Common Blinding Eye Condition AMD

Study demonstrates two different types of deposits in the retina that appear to contribute to age-related macular degeneration.

Featured Neuroscience Visual Neuroscience

·January 3, 2023·4 min read

Age-Related Macular Degeneration a Risk Factor for COVID-19 Infection and Severe Disease

More severe COVID-19 outcomes associated with age-related macular degeneration likely arise from a genetic predisposition in addition to higher levels of Pdgf in blood serum.

Featured Neuroscience Visual Neuroscience

·December 15, 2022·4 min read

Brain Stimulation Found to Improve Reading Ability in Macular Degeneration Patients

Transcranial direct current stimulation can help improve reading for those with age-related macular degeneration.

Featured Neurology Neuroscience Visual Neuroscience

·November 17, 2022·5 min read

Age-Related Macular Degeneration Associated With Serious Forms of Cardiovascular Disease

People with subretinal drusenoid deposits (SDD), a form of age-related macular degeneration, are more likely to have underlying heart damage as a result of heart failure or heart attacks, or other forms of cardiovascular disease associated with increased stroke risk.

Featured Neuroscience Visual Neuroscience

·September 7, 2022·4 min read

A Single Protein Could Unlock Age-Related Vision Loss

Determining the structure of vitronectin, a protein implicated in age-related macular degeneration and some neurodegenerative disorders, and using pressure to alter the protein shape may help in the development of new treatments for AMD.